The AHR as a therapeutic target for inflammatory skin diseases

被引:0
|
作者
van den Bogaard, Ellen [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dermatol, Nijmegen, Netherlands
关键词
D O I
10.1016/j.toxlet.2017.07.119
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
S19-05
引用
收藏
页码:S48 / S48
页数:1
相关论文
共 50 条
  • [41] The Skin Microbiome in Inflammatory Skin Diseases
    Norreslet, Line Brok
    Agner, Tove
    Clausen, Maja-Lisa
    CURRENT DERMATOLOGY REPORTS, 2020, 9 (02) : 141 - 151
  • [42] The Skin Microbiome in Inflammatory Skin Diseases
    Line Brok Nørreslet
    Tove Agner
    Maja-Lisa Clausen
    Current Dermatology Reports, 2020, 9 : 141 - 151
  • [43] JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases
    de Medeiros, Ana Karina Alves
    Speeckaert, Reinhart
    Desmet, Eline
    Van Gele, Mireille
    De Schepper, Sofie
    Lambert, Jo
    PLOS ONE, 2016, 11 (10):
  • [44] Fibrinogen-like protein 2 in inflammatory diseases: A future therapeutic target
    Fu, Li
    Liu, Zheng
    Liu, Yang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 116
  • [45] Visualizing Phosphodiesterase 8A: a novel therapeutic target for autoimmune and inflammatory diseases
    Vang, A.
    Nielsen, K. R.
    Kaminski, M.
    VIRCHOWS ARCHIV, 2014, 465 : S233 - S234
  • [46] CB2 receptor activation as a therapeutic target in inflammatory bowel diseases
    Yahalom, B.
    Yacovan, A.
    Aizikovich, A.
    Mirilashvili, S.
    Galili, Z.
    Avidor, B.
    Konforti, D.
    Kischitzky, A.
    Zawoznik, E.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (01) : S39 - S39
  • [47] The Role of ASIC1a in Inflammatory Immune Diseases: A Potential Therapeutic Target
    Wang, Yinghong
    Hu, Xiaojie
    Sun, Yancai
    Huang, Yan
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [48] Could IL-25 be a potential therapeutic target for intestinal inflammatory diseases?
    Chen, Jie
    Wang, Yingshu
    Shen, Lan
    Xiu, Yanfeng
    Wang, Bing
    CYTOKINE & GROWTH FACTOR REVIEWS, 2023, 69 : 43 - 50
  • [49] Activating transcription factor 3: A potential therapeutic target for inflammatory pulmonary diseases
    Li, Dandan
    Jing, Juanjuan
    Dong, Xue
    Zhang, Chenyang
    Wang, Jia
    Wan, Xianyao
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (09)
  • [50] Smad7 and its Potential as Therapeutic Target in Inflammatory Bowel Diseases
    Laudisi, Federica
    Dinallo, Vincenzo
    Di Fusco, Davide
    Monteleone, Giovanni
    CURRENT DRUG METABOLISM, 2016, 17 (03) : 303 - 306